❤️ Cold Email Automation
🤖 AI for Cold Outreach
🔥 Advanced Email Warm-up
🕵️ Mass Email Personalization
❤️ Free Tools
Pricing
Blog
Morphic Tx develops oral integrin therapies for patients with immunological, fibrotic, neoplastic, and vascular diseases. Building on the foundational work of Tim Springer, the company aims to make integrins accessible as small molecule drugs.